stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
90.48
3.30
+3.79%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Operating margin
Solventum Corporation's operating margin over the twelve months to 30 September 2026 was 0.00%, down 26.2 percentage points from fiscal 2025 (26.2%). That is below the Medical Instruments & Supplies industry median of 2.26% and in line with the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 26.2% | 13.65 |
| FY2024 | 12.6% | (8.09) |
| FY2023 | 20.6% | (0.18) |
| FY2022 | 20.8% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 0.00% | (8.19) |
| Jun 2026 | 8.19% | 4.20 |
| Mar 2026 | 3.99% | (2.27) |
| Dec 2025 | 6.26% | (74.37) |
| 11 more quarters | Free account |
Operating margin against peers
| Company | Operating margin |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 23.0% |
| ALGN Align Technology, Inc. compare | 14.9% |
| COO The Cooper Companies, Inc. compare | 12.8% |
| ATR AptarGroup, Inc. compare | 11.9% |
| AVTR Avantor, Inc. compare | 7.34% |
| BLCO Bausch + Lomb Corporation compare | 7.07% |
| RGEN Repligen Corporation compare | 2.26% |
| SOLV Solventum Corporation | 0.00% |
| BAX Baxter International Inc. compare | −1.90% |
| Medical Instruments & Supplies industry median | 2.26% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement